AOD9604 6mg

AOD-9604 is a synthetic peptide derived from a modified fragment of human growth hormone (hGH), corresponding to the hGH 176–191 region and containing a disulfide bridge. AOD9604 peptide research examines how this hexadecapeptide influences lipid metabolism–associated signaling in controlled laboratory systems. In preclinical settings, AOD9604 is commonly investigated for its effects on pathways associated with lipolysis and lipogenesis in adipose tissue models.

In vitro experiments and animal studies often evaluate changes in lipid handling markers, adipocyte metabolic activity, and downstream signaling events related to energy balance. Major research areas include adipose tissue metabolism, metabolic pathway regulation in models of altered nutrient handling, and exploratory studies in joint and cardiovascular biology using preclinical endpoints. These systems are important in laboratory research because they provide quantifiable readouts for studying peptide-mediated modulation of metabolic signaling without implying clinical efficacy or human use.

For research use only. Not for human consumption.

References:
Heffernan MA et al., Eur J Endocrinol, 2001 144:511-517
Ng FM et al., Drug Dev Res, 2000 51:63-71
Ng FM et al., Metabolism, 2002 51(12):1739-1743